Axa’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-62,153
| Closed | -$8.47M | – | 1389 |
|
|
2020
Q3 | $8.47M | Sell |
62,153
-602
| -1% | -$64K | 0.03% | 507 |
|
|
2020
Q2 | $6.06M | Buy |
62,755
+17,730
| +39% | +$1.48M | 0.02% | 555 |
|
|
2020
Q1 | $2.11M | Sell |
45,025
-27,895
| -38% | -$1.79M | 0.01% | 721 |
|
|
2019
Q4 | $5.32M | Buy |
72,920
+1,822
| +3% | +$111K | 0.02% | 600 |
|
|
2019
Q3 | $3.71M | Buy |
+71,098
| New | +$3.78M | 0.01% | 741 |
|
|
2018
Q4 | – | Sell |
-4,700
| Closed | -$306K | – | 1407 |
|
|
2018
Q3 | $306K | Sell |
4,700
-2,500
| -35% | -$147K | ﹤0.01% | 1226 |
|
|
2018
Q2 | $357K | Sell |
7,200
-101,528
| -93% | -$4.92M | ﹤0.01% | 1195 |
|
|
2018
Q1 | $5.31M | Sell |
108,728
-1,224
| -1% | -$63.6K | 0.02% | 633 |
|
|
2017
Q4 | $4.63M | Buy |
109,952
+45,397
| +70% | +$1.75M | 0.02% | 674 |
|
|
2017
Q3 | $2.77M | Buy |
+64,555
| New | +$2.06M | 0.01% | 761 |
|
Axa's MYOK Position: Q4 2020 in Review
Axa sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 62,153 shares — an estimated $8.47M sold.
Axa first reported a position in MYOK in Q3 2017 and held it in 10 quarters. The position peaked at $8.47M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Axa reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Axa sold 62,153 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $8.47M.
- Axa first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 10 quarters.
- Axa's MyoKardia, Inc. Common Stock position peaked at $8.47M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.